Breaking News

Advent International, Warburg Pincus Acquire Baxter’s BPS Biz for $4.25B

Standalone CDMO will operate under the name Simtra BioPharma Solutions.

Advent International, a global private equity investor, and Warburg Pincus, a global growth investor, completed their previously announced acquisition of Baxter International Inc.’s BioPharma Solutions (BPS) business. The business will now be a standalone contract development and manufacturing organization (CDMO) operating under the name Simtra BioPharma Solutions and will continue to offer customers the same services and capabilities to support the supply of critical pharmaceutical products ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters